
Please try another search
Teladoc, Inc. (NYSE:TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022. The company also expects to provide the initial purchaser an option to buy up to an additional $30 million aggregate principal amount of notes on the same terms and conditions, solely to cover over-allotments.
Teladoc will use proceeds from the offering to fund a portion of the cash payable for its recently announced acquisition of Best Doctors Holdings, Inc., the world’s leading expert medical consultation company. The acquisition primarily aims at improving health outcomes for the most complex, critical and costly medical issues. Teladoc basically intends to create a new paradigm for patients to access care by delivering a powerful connected care platform.
This apart, the company also intends to refinance existing indebtedness and to pay related fees and expenses. The remaining proceeds will be utilized for working capital and other general corporate purposes.
Teladoc’s strategic initiatives to improve profitability and reduce liabilities make it well positioned for future growth. Year to date, shares of Teladoc have rallied 98% outperforming the Zacks categorized Medical Service industry’s gain of only 6%.
At the end of first-quarter 2017, Teladoc had $42 million of long-term debt, up 68% from the year-ago quarter and unchanged from year-end 2016.. Its interest expense also rose 63% year over year but declined 46% from year-end 2016.
Zacks Rank and Stocks to Consider
Teladoc presently has a Zacks Rank #3 (Hold). Investors can consider some better-ranked stocks like Align Technology, Inc. (NASDAQ:ALGN) , EDAP TMS S.A. (NASDAQ:EDAP) and Inogen Inc. (NASDAQ:INGN) . All of the stocks sport a Zacks Rank #1(Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology, a medical dental supplies company, topped estimates in each of the last four quarters with an average beat of 59.23%.
Inogen is a medical instruments seller, which delivered positive surprises in each of the last four quarters with an average beat of 82.42%.
EDAP TMS also posted positive surprises in two of the last four quarters with an average beat of 366.67%.
Zacks' Hidden Trades
While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?
Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trade>>
Home improvement retailers Lowe’s (NYSE:LOW) and Home Depot (NYSE:HD) turned a corner, and their Q4 2024 earnings reports confirmed it. The corner is a return to comparable store...
One of our old flames, a former Contrarian Income Portfolio holding, has pulled back sharply in recent weeks. Time to buy the dip in this 4.3% dividend? Let’s discuss. Kinder...
Emini S&P March collapsed on Thursday from strong resistance at 6010/6015The low and high for the last session were 5873 - 6014.(To compare the spread to the contract you...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.